Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · MAXHEALTH

MAXHEALTH

HealthcareHealthcare Services₹99472 cr market cap
₹1036.75 ▲ +1.36% today As of 19 Nov 2026
52-week low ₹815.0052-week high ₹1181.10

-13.4% from the 52-week high · +25.5% above the low

Max Healthcare Institute Ltd. engages in the management and operation of hospitals and specialty clinics. The firm operates through the Medical and Healthcare Services segment. The firm also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. Max Lab provides pathology services outside its hospital network. The firm is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. The firm owns, operates and provides medical services to facilities in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. The company has approximately 17 healthcare facilities.

The short version. MAXHEALTH reported revenue of ₹2,569 crore for Sep 2026, up 20.3% from a year earlier. Net profit was ₹415 crore (down 15.5% year on year). Return on equity was 13.4% in Mar 2026. Promoter holding was 23.71% in Sep 2026, down 0.03 points over 8 quarters.

1 · The price

How has the stock traded?

MAXHEALTH trades 13.4% below its 52-week high and 25.5% above its 52-week low.

Change over period: —

1M+23.2%
3M+2.6%
6M-4.9%
1Y-8.4%

2 · The business

Is it growing?

Sales, year on year+20.3%

Sep 2026 revenue of ₹2,569 cr.

Profit, year on year-15.5%

Sep 2026 net profit of ₹415 cr.

Net margin16.2%

6.8 pts lower than a year earlier.

3-year growth9.3% profit

Revenue compounded at 22.0% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue25692366214320682135202819101868
Net profit415323342301491308319239
Net margin %16.213.616.014.623.015.216.712.8
EPS (₹)4.263.323.523.095.053.173.282.46

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue837370285406456339312505
Net profit1442107610581104605-137
Net margin %17.215.319.624.215.4-5.5
EPS (₹)14.8211.0710.8811.376.24-1.42

3 · The quality

How well does it turn capital into profit?

Return on equity was 13.4% in Mar 2026; debt to equity is 0.32.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %13.411.512.614.9
Return on capital %12.711.713.312.7
EBITDA margin %27.626.929.929.3
Net margin %16.915.018.923.5

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR22.0%26.7%
Profit CAGR9.3%—
Debt to equity0.32
Interest cover8.1x
Current ratio0.89
P/E ratio72.2

4 · The owners

Who holds it, and are they adding?

Promoter holding23.71%

Down 0.03 pts over 8 quarters.

Foreign institutions40.52%

Down 16.41 pts over 8 quarters.

Domestic institutions31.0%

Up 15.45 pts over 8 quarters.

Mutual fund schemes308

+90 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter23.7423.7423.7423.7423.7223.7123.7123.71-0.03
FII56.9354.7454.7651.850.5545.3941.7840.52-16.41
DII15.5517.5817.4220.0321.226.3229.9631.0+15.45
Public3.773.944.084.434.524.574.564.76+0.99

Mutual fund holdings · Oct 2026

308 schemes hold this stock

218 the month before.

  • Groww BSE Hospitals ETF18.92% of NAV
  • Invesco India Pharma and Healthcare Fund8.59% of NAV
  • Invesco India Mid cap Fund7.86% of NAV
  • Invesco India Large & Mid Cap Fund6.88% of NAV
  • Bandhan Healthcare Fund5.56% of NAV
  • ICICI Prudential Nifty Healthcare ETF5.55% of NAV
  • Axis NIFTY Healthcare ETF5.55% of NAV
  • DSP Nifty Healthcare ETF5.55% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for MAXHEALTH are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Corporate actions

Recent dividends, bonuses and splits

  • 03 Jul 2026 · Final Dividend - Rs. 2
  • 04 Jul 2025 · Final Dividend - Rs. 1.5
  • 23 Aug 2024 · Final Dividend - Rs. 1.5
  • 08 Sep 2023 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.